News & Events

The Latest from Lightship

Lightship Co-Founder Sam Eells & CCO Rachael Scott on the “Third Place” in Clinical Trials: SCOPE EU Presentation - April 15, 2022

Lightship Co-Founder Sam Eells & CCO Rachael Scott on the “Third Place” in Clinical Trials: SCOPE EU Presentation Prioritizing patient choice in clinical research means meeting people where they are and breaking down the barriers that prevent underrepresented groups from participating in clinical trials. Sam Eells, Co-Founder and Rachael Scott, Chief Commercial Officer, are presenting […]

The Sky’s the Limit for Virtual-First & Hybrid Clinical Trials: David MacMurchy on “Ian King Live” - April 14, 2022

They Sky’s the Limit for Virtual-First & Hybrid Clinical Trials: David MacMurchy on “Ian King Live” Lightship CEO David MacMurchy shared insights about virtual-first and hybrid clinical trials on “Ian King Live” on Sky News on Tuesday, April 12th. The popular London-based program covers the latest business and economic stories and has robust international reach. […]

Lightship to Participate at Goldman Sachs’ - April 7, 2022

‘Privates Leading the Disruption in Healthcare’ Conference David MacMurchy, CEO and Robert Jones, Chief Financial Officer, Lightship, a leading provider of virtual-first and hybrid clinical research services, are presenting at a Goldman Sachs on-campus global event on the changing role of clinical trial development in the age of precision medicine NEW YORK, NY – APRIL […]

Lightship Raises $40 Million to Bring Clinical Trials to Every Patient in Need - October 28, 2021

New funding will drive expansion, including in international markets; London office to open this Fall in United Kingdom. Expansion underpinned by new senior hires, including Chief Financial Officer; new roles of Chief Operating Officer and Chief Client Officer also created.

Lightship, Inc. Market Research Confirms Patients’ Interest in Direct-to-Patient Clinical Trial Offering Amidst COVID-19 Pandemic - May 29, 2020

Results of a nationwide survey, capturing patients’ opinions on direct-to-patient clinical trial participation during the COVID-19 pandemic.